Status:
COMPLETED
Evaluation of the Ambuja Cement Foundation Noncommunicable Disease Program in Bathinda District of Punjab, India
Lead Sponsor:
Harvard School of Public Health (HSPH)
Collaborating Sponsors:
Ambuja Cement Foundation
Conditions:
Non Communicable Diseases
Blood Pressure
Eligibility:
All Genders
30+ years
Phase:
NA
Brief Summary
This is an academic evaluation of a program being implemented by the Ambuja Cement Foundation (ACF). The aim of the evaluation is to determine the effect of the ACF noncommunicable disease (NCD) progr...
Detailed Description
Evaluation visits will be conducted at the participant's home. At baseline, the ACF field team will first administer a screening questionnaire to all adults in the household to confirm eligibility. Fo...
Eligibility Criteria
Inclusion
- • Reside in the study area (12 villages in Bathinda District of Punjab, India). "Residence" will be defined as sleeping in a house in that village on a typical weeknight.
- ≥30 years old. Age will be confirmed by directly viewing a government-issued document with the individual's date of birth.
- Willing to provide informed consent.
Exclusion
- • Plan to move permanently out of the study area in the next 12 months.
- Pregnant (women via self-report).
- Persons who are bedridden or mentally challenged.
- Persons who speak a language other than Punjabi, Hindi, or English
Key Trial Info
Start Date :
July 30 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2024
Estimated Enrollment :
11322 Patients enrolled
Trial Details
Trial ID
NCT04827615
Start Date
July 30 2019
End Date
September 30 2024
Last Update
February 14 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ambuja Cement Foundation
Bathinda, Punjab, India